|
Volumn 45, Issue 5, 2010, Pages 1753-1759
|
Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies
|
Author keywords
1,3,4 Oxadiazoles; 2 Mercapto benzimidazole; 4 Thiazolidinones; Anticonvulsant; Antidiabetic; DNA cleavage
|
Indexed keywords
1,3,4 OXADIAZOLE DERIVATIVE;
2 [5 (2 CHLORO 4 NITRO PHENYL)[1,3,4]OXADIAZOLE 2 YLMETHYLSULFANYL] 1H BENZIMIDAZOLE;
2 [5 (4 NITRO PHENYL)[1,3,4]OXADIAZOLE 2 YLMETHYLSULFANYL] 1H BENZIMIDAZOLE;
2 BENZIMIDAZOLETHIOL DERIVATIVE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (2 HYDROXY 3 METHOXY PHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (2 HYDROXY PHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (3 HYDROXYNAPHTHALEN 2 YL) THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (4 HYDROXY PHENYL)THIAZOLIDIN 4 ONE;
3 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL]NAPHTHALENE 2 OL;
4 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL]PHENOL;
4 THIAZOLIDINONE DERIVATIVE;
ANTICONVULSIVE AGENT;
ANTIDIABETIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
CARBAMAZEPINE;
DNA;
GLIBENCLAMIDE;
PHENYTOIN;
UNCLASSIFIED DRUG;
ANTICONVULSANT ACTIVITY;
ANTIDIABETIC ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
CONVULSION;
DNA CLEAVAGE;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
HYPERGLYCEMIA;
IN VIVO STUDY;
MALE;
NONHUMAN;
ORAL GLUCOSE TOLERANCE TEST;
PHARMACOPHORE;
RAT;
ANIMALS;
ANTICONVULSANTS;
BENZIMIDAZOLES;
DIABETES MELLITUS, EXPERIMENTAL;
DNA CLEAVAGE;
DNA, BACTERIAL;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HYPOGLYCEMIC AGENTS;
MALE;
MOLECULAR STRUCTURE;
MOTOR ACTIVITY;
RATS;
RATS, WISTAR;
ROTAROD PERFORMANCE TEST;
SEIZURES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 77949486916
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2010.01.007 Document Type: Article |
Times cited : (241)
|
References (31)
|